Our mission is to improve the care of rare liver disease patients throughout Europe

Latest Covid update on the general pandemic situation and the impact on rare liver disease patients

A click on the button will establish a connection to YouTube.
This may result in YouTube being able to collect personal information.
Please refer to our Privacy notice for further information.

General Covid update and the impact on rare liver disease patients

Both the covid pandemic and the prospect of new vaccines have changed the general situation significantly in recent weeks. For patients with rare liver diseases, the situation is much more complicated and the questions even more specific.

VALDIG-ERN-EASL Webinar: Management of pregnant women with vascular liver disorders and portal hypertension, 11 October 2022, 17:00-18:00 CEST


Aurélie Plessier/ Filipe Nery

Latest press release: Acute liver inflammation (hepatitis) of unknown origin in children: an update

Unexplained cases of acute liver inflammation in children, especially in the United Kingdom (UK) were reported earlier this year. In response, the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) conducted a thorough investigation that did not confirm the alarming observation from the UK in other European countries.

New EASL Clinical Practice Guidelines on Sclerosing Cholangitis

We would like to draw your attention to the new EASL Clinical Practice Guideline on Sclerosing Cholangitis, which has been published in June 2022. We are grateful to all the authors and panelists, most of them from ERN centres.

Scientific News